Beacon Pharmaceutical (New York, N.Y.) said it will launch a new platform to connect terminally ill patients with experimental therapies under the new right-to-try law. READ ARTICLE
Biocentury: BEACON TO DEVELOP RIGHT-TO-TRY PATIENT MATCH PLATFORM
6 views
